Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
55.1M
-
Shares change
-
-1.05M
-
Total reported value, excl. options
-
$544M
-
Value change
-
-$11.3M
-
Put/Call ratio
-
0.45
-
Number of buys
-
91
-
Number of sells
-
-75
-
Price
-
$9.88
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2022
200 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2022.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.1M shares
of 58.9M outstanding shares and own 93.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.8M shares), VANGUARD GROUP INC (3.89M shares), STATE STREET CORP (3.69M shares), RENAISSANCE TECHNOLOGIES LLC (3.3M shares), MACQUARIE GROUP LTD (2.93M shares), DIMENSIONAL FUND ADVISORS LP (2.73M shares), Epoch Investment Partners, Inc. (2.72M shares), Palo Alto Investors LP (2.17M shares), GOLDMAN SACHS GROUP INC (1.7M shares), and Assenagon Asset Management S.A. (1.59M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.